No Pharma Money
All News & Reports

Press Releases

Statements and announcements from Patients For Affordable Drugs NOW.

Stay Up To Date

News and reports from P4ADNow

Press Releases Sep 19, 2019

Statement: Let Medicare Negotiate

In response to today’s release of a bill by House leadership that would lower drug prices for Americans, Ben Wakana, Executive Director of Patients For Affordable Drugs Now, issued the following statement:

Read Article
Press Releases Sep 10, 2019

STATEMENT: Americans Will Pay Lower Prices Under New House Drug Plan

David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now, issued the following statement in response to a draft plan in the House of Representatives that would lower drug…

Read Article
Press Releases Jul 31, 2019

STATEMENT: Patients For Affordable Drugs Now Endorses Bipartisan We PAID Act of 2019

With the introduction of the bipartisan We PAID Act of 2019, federal lawmakers are taking a stand today to assure drug companies set reasonable prices for prescription drugs funded with taxpayer investment.

Read Article
Press Releases Jul 23, 2019

STATEMENT: Patients Applaud Bipartisan Senate Finance Plan to Lower Drug Prices

In response to the news that the Senate Finance Committee Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) released a slate of reforms to lower prescription drug prices for patients…

Read Article
Press Releases Jun 26, 2019

STATEMENT: Patients Applaud Inclusion of the FAIR Drug Pricing Act in the Senate HELP Committee Package

In response to today’s HELP Committee vote to include the FAIR Drug Pricing Act in the Lower Health Care Costs Act of 2019, Patients For Affordable Drugs Now Executive Director Ben Wakana issued the following statement:

Read Article
Press Releases Jun 21, 2019

STATEMENT: Patients For Affordable Drugs Now Applauds Forward Movement of HHS Rule to Lower Drug Prices in Medicare

In response to news that the U.S. Department of Health and Human Services’ proposal to lower drug prices in Medicare Part B is under review by the Office of Management and Budget, Patients For…

Read Article
Press Releases May 9, 2019

Patients For Affordable Drugs Now Endorses New Drug Pricing Bill

In light of today’s news that Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT) introduced a groundbreaking bipartisan bill that would outlaw two tactics Big Pharma wields to maintain…

Read Article
Press Releases May 1, 2019

Statement on House Judiciary Committee Passing Package of Bills to Address Rising Drug Prices

In response to the House Judiciary Committee passing a legislative package that would stop REMS abuses, curb anti-competitive pay-for-delay deals, address sham citizen petitions, and regulate PBM…

Read Article
Press Releases Apr 9, 2019

Statement on Unanimous Committee Passage of Legislation to Address Rising Drug Prices

In response to the House Ways and Means Committee unanimously passing H.R. 2113, legislation aimed at stopping drug price gouging and shedding light on secret PBM activity, Ben Wakana, the Executive…

Read Article
Press Releases Apr 4, 2019

Statement on Committee Passage of Two Bills to Address Rising Drug Prices

In response to the House Energy and Commerce Committee passing the CREATES Act and legislation to end pay-for-delay tactics, David Mitchell, a cancer patient and the founder of Patients For…

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.